As part of a newly formed strategic relationship, Atlanta-based McKesson will incorporate the risk prediction capabilities from Proventys Inc. (Durham, N.C.) into its core clinical decision support solutions.
Proventys is a personalized medicine knowledge service provider that translates predictive data from traditional and emerging diagnostic tests, including genomics, proteomics, and metabolomics, into clinical decision support solutions, according to the company.
